Targeted Genome Editing Using TALENs to Correct a Mouse Model of Methylmalonic Acidemia (MMA)

被引：0
|
作者：
Schneller, Jessica L. [1 ]
Chandler, Randy J. [1 ]
Venditti, Charles P. [1 ]
机构：
[1] NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33168-9
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
359
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [21] TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
    Mussolino, Claudio
    Alzubi, Jamal
    Fine, Eli J.
    Morbitzer, Robert
    Cradick, Thomas J.
    Lahaye, Thomas
    Bao, Gang
    Cathomen, Toni
    NUCLEIC ACIDS RESEARCH, 2014, 42 (10) : 6762 - 6773
  • [22] TALENs Facilitate Targeted Genome Editing in Human Cells With High Specificity and Low Cytotoxicity
    Mussolino, Claudio
    Alzubi, Jamal
    Fine, Eli J.
    Morbitzer, Robert
    Cradick, Thomas J.
    Lahaye, Thomas
    Bao, Gang
    Cathomen, Toni
    MOLECULAR THERAPY, 2014, 22 : S95 - S95
  • [23] MALE GENOME EDITING AT THE GAMETE LEVEL TO CORRECT PATHOLOGICAL MUTATIONS IN A MOUSE MODEL.
    De Jesus, Angela Bryanne
    Pizzo, Elena
    Xie, Philip
    Aluko, Ashley
    Rosenwaks, Zev
    Palermo, Gianpiero D.
    FERTILITY AND STERILITY, 2023, 120 (04) : E102 - E102
  • [24] Highly Efficient and Specific Genome Editing in Silkworm Using Custom TALENs
    Ma, Sanyuan
    Zhang, Shengling
    Wang, Feng
    Liu, Yong
    Liu, Yuanyuan
    Xu, Hanfu
    Liu, Chun
    Lin, Ying
    Zhao, Ping
    Xia, Qingyou
    PLOS ONE, 2012, 7 (09):
  • [25] Genome Editing Using TALENs in Blind Mexican Cavefish, Astyanax mexicanus
    Ma, Li
    Jeffery, William R.
    Essner, Jeffrey J.
    Kowalko, Johanna E.
    PLOS ONE, 2015, 10 (03):
  • [26] Promoterless, Nuclease-Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia
    Chandler, Randy J.
    Venturoni, Leah E.
    Liao, Jing
    Hubbard, Brandon T.
    Schneller, Jessica L.
    Hoffmann, Victoria
    Gordo, Susana
    Zang, Shengwen
    Ko, Chih-Wei
    Chau, Nelson
    Chiang, Kyle
    Kay, Mark A.
    Barzel, Adi
    Venditti, Charles P.
    HEPATOLOGY, 2021, 73 (06) : 2223 - 2237
  • [27] A Partial Deficiency Model of MUT Methylmalonic Acidemia (MMA) Displays Diet Inducible Disease and Sensitivity to Acetaminophen (APAP)
    Senac, Julien S.
    Aswani, Vijay H.
    Sysol, Justin R.
    Manoli, Irini
    Venditti, Charles P.
    MOLECULAR THERAPY, 2013, 21 : S107 - S107
  • [28] Early dose response data with homologous recombination-based genome editing approach using a promoterless AAV vector in mice with methylmalonic acidemia
    Zhang, S.
    Bastille, A.
    Taylor, R.
    Liao, J.
    Chiang, K.
    Chau, N.
    HUMAN GENE THERAPY, 2018, 29 (12) : A129 - A129
  • [29] THE RENAL DISEASE OF METHYLMALONIC ACIDEMIA: INSIGHTS INTO PATHOPHYSIOLOGY USING MOUSE MODELS AND HUMAN STUDIES
    Manoli, I.
    Sloan, J.
    Sysol, J. R.
    Chandler, R. J.
    Cusmano-Ozog, K.
    Zerfas, P.
    Hoffmann, V.
    Abu-Asab, M.
    Tsokos, M.
    Enns, G. M.
    Venditti, C. P.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (03) : 224 - 224
  • [30] Treatment of Methylmalonic Acidemia by Targeted Integration of MUT into Albumin Using an Optimized Promoterless AAV Vector
    Venturoni, Leah E.
    Chandler, Randy J.
    Chau, Nelson
    Liao, Jing
    Kay, Mark A.
    Barzel, Adi
    Venditti, Charles P.
    MOLECULAR THERAPY, 2019, 27 (04) : 367 - 367
12345